Phospholipase C gamma 2 (PLCγ2)

Phospholipase C gamma 2 (PLCγ2) is a transmembrane signaling enzyme primarily expressed in hematopoietic cells, including B cells and microglia. It serves as a critical signaling hub, catalyzing the conversion of the membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). These molecules trigger intracellular calcium release and activate protein kinase C, mediating essential cellular processes such as proliferation, differentiation, and phagocytosis. In the brain, PLCγ2 is a key effector downstream of the TREM2 receptor, which is vital for microglial responses to neurodegenerative pathology. PLCγ2 has emerged as a significant therapeutic target in both oncology and neurodegeneration. In hematologic malignancies like chronic lymphocytic leukemia (CLL), acquired mutations in the PLCG2 gene are a primary driver of resistance to Bruton's tyrosine kinase (BTK) inhibitors. Conversely, in Alzheimer's disease, a rare protective variant (P522R) has been identified as a functional hypermorph, leading to the development of small-molecule activators designed to enhance microglial clearance of amyloid-beta plaques. However, targeting this enzyme presents safety challenges, as gain-of-function mutations are associated with severe autoinflammatory syndromes (APLAID), while loss-of-function can lead to antibody deficiencies (PLAID).

Other names

1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2Phosphatidylinositol-specific phospholipase C, gamma 2PLC-IVPLCG2APLAIDFCAS3

Direct inhibitors block the enzymatic cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), thereby reducing intracellular calcium mobilization and protein kinase C (PKC) activation to suppress aberrant B-cell or inflammatory signaling. Small molecule activators aim to enhance this catalytic activity (mimicking the P522R protective variant) to promote neuroprotective microglial functions, such as the phagocytosis and clearance of amyloid-beta plaques in neurodegenerative conditions.